Tourette Syndrome is a hereditary disorder that begins in childhood. The disorder is characterized by sudden, rapid, recurrent, nonrhythmic movements (motor tics) or sounds (vocal or phonic tics), usually accompanied by neuropsychiatric disorders such as ADHD, anxiety or obsessive-compulsive disorder (OCD).
There are various behavioral interventions and electrical devices that are useful in treating the involuntary movements or neuropsychiatric symptoms of Tourette Syndrome, but often adjunctive pharmacological therapies are necessary to achieve good outcomes.
At 7:30 p.m. EST TONIGHT, a New Jersey Center for Tourette Syndrome & Associated Disorders (NJCTS) Wednesday Webinar will explain the biological rationale for using medications for tics and Tourette Syndrome, the various types of drugs that have shown to be beneficial, and discuss the risks and benefits of medication therapies.
This webinar is for professionals, therapists and persons and their families dealing with Tourette Syndrome and associated disorders. To register for this webinar, please click here. To view and download past NJCTS webinars, please click here.
NJCTS launched the monthly Wednesday Webinar series, which draws an audience from 48 states and 13 countries, in 2008. The series, offered at no cost to participants, features online seminars for parents, educators and professionals on topics of interest to the TS and associated disorders community. Professional development credits are given upon verification of attendance and completion of an exit survey. Credits are distributed by mail one week after the webinar.